CAT-8015
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CAT-8015, covering 2011-11-22 to 2018-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL) [Phase 1, Phase 2]